(Press-News.org) ROCHESTER, Minn. -- A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.
"There has been a great deal of debate about the effectiveness of bevacizumab in treating patients with glioblastoma," says lead author Derek Johnson, M.D., a neuro-oncologist at Mayo Clinic Cancer Center. "Our study found that, at the population level, treatment strategies involving bevacizumab prolonged survival in patients with progressive glioblastoma."
Researchers analyzed data on 5,607 adult patients from the National Cancer Institute (NCI) Surveillance, Epidemiology and End Results (SEER) database before and after the conditional approval of bevacizumab for the treatment of glioblastoma in 2009. The SEER database covers 18 geographic areas of the U.S., which collectively represent 28 percent of the U.S. population.
Researchers studied survival in 1,715 patients with glioblastoma who died in 2006, 1,924 who died in 2008 and 1,968 who died in 2010. "The difference in survival between 2008 and 2010 was highly significant and likely unrelated to any advancements in supportive care," Dr. Johnson says. "This study provides the strongest evidence to date that bevacizumab therapy improves survival in patients with glioblastoma."
Glioblastoma, is an aggressive cancer in which tumors grow rapidly and spread rapidly to new sites. It is the most common malignant brain tumor in adults and accounts for about 22 percent of all brain cancers. About 3,000 people develop a glioblastoma each year in the U.S.
###
Co-authors include Heather Leeper, M.D., and Joon Uhm, M.D. both of Mayo Clinic.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call
507-538-7623
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and http://www.mayoclinic.org/news.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
Brain cancer survival improved following FDA approval of bevacizumab, Mayo study finds
2013-08-19
ELSE PRESS RELEASES FROM THIS DATE:
How shale fracking led to an Ohio town's first 100 earthquakes
2013-08-19
Since records began in 1776, the people of Youngstown, Ohio had never experienced an earthquake. However, from January 2011, 109 tremors were recorded and new research in Geophysical Research-Solid Earth reveals how this may be the result of shale fracking.
In December 2010, Northstar 1, a well built to pump wastewater produced by fracking in the neighboring state of Pennsylvania, came online. In the year that followed seismometers in and around Youngstown recorded 109 earthquakes; the strongest being a magnitude 3.9 earthquake on December 31, 2011.
The study authors ...
3-D images show flame retardants can mimic estrogens in NIH study
2013-08-19
By determining the three-dimensional structure of proteins at the atomic level, researchers at the National Institutes of Health have discovered how some commonly used flame retardants, called brominated flame retardants (BFRs), can mimic estrogen hormones and possibly disrupt the body's endocrine system. BFRs are chemicals added or applied to materials to slow or prevent the start or growth of fire.
"We're beginning to have a better understanding of flame retardants and their effect on human health. This particular study helps us literally see what brominated flame retardants ...
Study finds cost of future flood losses in major coastal cities could be over $50 billion by 2050
2013-08-19
Climate change combined with rapid population increases, economic growth and land subsidence could lead to a more than nine-fold increase in the global risk of floods in large port cities between now and 2050.
'Future Flood Losses in Major Coastal Cities', published in Nature Climate Change, is part of an ongoing project by the Organisation for Economic Co-operation and Development (OECD) to explore the policy implications of flood risks due to climate change and economic development. This study builds on past OECD work which ranked global port cities on the basis of ...
The concussed brain at work: fMRI study documents brain activation during concussion recovery
2013-08-19
For the first time, researchers have documented irregular brain activity within the first 24 hours of a concussive injury, as well as an increased level of brain activity weeks later—suggesting that the brain may compensate for the injury during the recovery time.
The findings are published in the September issue of the Journal of the International Neuropsychological Society.
Thomas Hammeke, PhD, professor of psychiatry and behavioral medicine at the Medical College of Wisconsin, is the lead author. Collaborators at the Cleveland Clinic; St. Mary's Hospital in Enid, ...
Cancer surgery patients have more complications, but less likely to die
2013-08-19
DETROIT – While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.
The finding, part of a first-of-its-kind study by researchers at Henry Ford Hospital and others in the U.S., Canada and Germany, could lead to recommended changes in national health care policy and a reallocation of resources.
The study was published online in British Medical Journal Open.
Jesse Sammon, D.O., Henry Ford Hospital urologist, research fellow and co-author of the paper, says the ...
Therapeutic eye injections may be needed less often
2013-08-19
Johns Hopkins biomedical engineers have teamed up with clinicians to create a new drug-delivery strategy for a type of central vision loss caused by blood vessel growth at the back of the eye, where such growth should not occur. In addition to testing a new drug that effectively stops such runaway vessel growth in mice, the team gave the drug a biodegradable coating to keep it in the eye longer. If proven effective in humans, the engineers say, it could mean only two or three needle sticks to the eye per year instead of the monthly injections that are the current standard ...
Child health concerns vary among different races, ethnicities
2013-08-19
ANN ARBOR, Mich. – Adults across the U.S. rate childhood obesity as the top health concern for children in 2013, but priorities vary based on racial and ethnic backgrounds, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.
In the poll's annual top 10 list, a nationwide sample of adults were asked to identify the top 10 biggest health concerns for kids in their communities. Overall, childhood obesity is rated at the top of the list (38 percent of adults said obesity is a 'big problem' for children in their communities). ...
NASA satellite sees Pewa become a typhoon
2013-08-19
NASA's Aqua satellite passed over the tropical cyclone known as Pewa after it strengthened into a typhoon in the northwestern Pacific Ocean. The Aqua satellite image revealed that Pewa had developed a small eye.
On Sunday, Aug. 18, Pewa was a tropical storm when it crossed the International Date Line and moved from the Central Pacific to the Northwestern Pacific Ocean. Pewa now falls under the forecast authority of the Joint Typhoon Warning Center.
On Aug. 18, infrared satellite data showed that thunderstorm development and convection had slightly weakened, but the ...
NASA sees Tropical Storm Trami U-turning
2013-08-19
Tropical Storm Trami appears to be a very large storm in infrared data from NASA's Aqua satellite. In a NASA image, Trami appears to be about two-thirds the size of the Philippines. Satellite data also indicates that the massive storm is now making a U-turn in the Northwestern Pacific Ocean, from a southeastern path to a northwestern path.
When NASA's Aqua satellite passed over Tropical Storm Trami on Aug. 18, the AIRS instrument aboard captured an infrared image that showed a large area of thunderstorm activity within the storm. The Aqua satellite passed over Trami at ...
NASA catches short-lived northwestern Pacific Ocean Tropical Depression 13W
2013-08-19
The thirteenth Tropical Depression of the Northwestern Pacific Ocean season didn't last long. In fact, Tropical Depression 13W lived for less than a day as a depression before fizzled.
TD13W was "born" at 1500 UTC/11 a.m. EDT on Aug. 17 with maximum sustained winds near 25 knots. Later that day at 2100 UTC/5 p.m. EDT, the Joint Typhoon Warning Center issued its final bulletin on the depression. At that time it was located near 28.0 north latitude and 126.0 east longitude, about 109 nautical miles northwest of Kadena Air Base, Japan.
Before TD13W dissipated, the MODIS ...